Comparison of predialysis characteristics of the postdialysis 30-day survival and mortality patients.

NOTE. Data are number (%) of patients, unless otherwise indicated.
Abbreviation: APACHE II, acute physiology and chronic health evaluation; CVP, central venous pressure; CVVH, continuous venovenous hemofiltration; ECMO, extracorporeal membrane oxygenation; IABP, intraaortic balloon pump; MAP, mean arterail pressure; NPO, nil per os; RIFLE, risk of renal failure, injury to kidney, failure of kidney function, loss of kidney function, and end-stage renal failure (RIFLE) classification; SD, standard deviation; SOFA, Sequential Organ Failure Assessment; SAPS, simplified acute physiological score; IHD, intermittent hemodialysis; sCr, serum creatinine, SLED, sustained low-efficiency dialysis.
§Data correspond to the worst value in the 24 hours preceding the time point.
∥Defined as 3-day predialysis diuretic use.

注：若无特殊说明，数据以患者例数（百分比）形式呈现。
缩写说明：APACHE II（急性生理学与慢性健康状况评分系统Ⅱ）；CVP（中心静脉压）；CVVH（连续性静脉-静脉血液滤过）；ECMO（体外膜肺氧合）；IABP（主动脉内球囊反搏）；MAP（平均动脉压）；NPO（经口禁食，nil per os）；RIFLE分类（肾损害风险、肾损伤、肾功能衰竭、肾功能丧失及终末期肾衰竭分层标准）；SD（标准差）；SOFA（序贯器官衰竭评分）；SAPS（简化急性生理学评分）；IHD（间歇性血液透析）；sCr（血清肌酐）；SLED（持续性低效透析）。
§ 数据对应于采样时间点前24小时内的最差观测值。
∥ 定义为透析前3天的利尿剂使用情况。